Log inSign up
AAOIFI No. 21 screening

Is ALMR halal?

Alamar Biosciences, Inc.

Halal

Alamar Biosciences, Inc. passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 14 October 2026

Exchange

NASDAQ

Price

25.28

Day

-7.80%

Market cap

$1.70B

Industry

Medical Devices

Sector

Healthcare

What the company does

Alamar Biosciences (IPO 2026) makes proteomics instruments: the ARGO system and NULISA reagents that measure very low-abundance protein biomarkers in blood (research use). Its money comes from instrument and consumables sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $9.95M ÷ current market cap $1.70B = 0.6%

    0.6%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $250.05M ÷ current market cap $1.70B = 14.7%

    14.7%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $2.16M ÷ annual revenue $74.21M (2025) = 2.9%

    2.9%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

For information (AAOIFI 3/1 note): cash + receivables are 69.2% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.00% · #807 of 1454

Halal stocks in the same industry

The largest halal stocks in Medical Devices — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.